News

There's much to do and see in San Francisco, where the American Academy of Ophthalmology (AAO) 2023 annual meeting will run from Friday 3 November through Monday 6 November

Data from the study, presented at the 2023 American Academy of Ophthalmology meeting in San Francisco, support the implantation of the LAL in eyes that had undergone a previous RK

Study results indicated low-light therapy can help prevent dry eye disease following cataract surgery

Innovative new features build on the benefits of the iCare COMPASS Automated Perimeter

Commercial airline pilots work mandates the ability to see clearly at multiple distances from near to far under a variety of conditions. This Case of the Month highlights the impact of prespyopia on visual functions for pilots and that ZEISS PRESBYOND can be a great option to consider improving the ability to perform the full range of their occupational vision-related tasks with high patient satisfaction after surgery.

No two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence

Surgeons can save space and optimise workflow efficiency in the operating room

The collection at the Truhlsen-Marmor Museum of the Eye includes more than 38,000 objects, including rare books, instruments and immersive educational materials.

According to Genentech, RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular oedema

The patent is also being prosecuted in the European Union and around the globe

For clinicians, the evolution of treatment is as much a responsibility as an opportunity

Several companies including Kiora Pharmaceuticals, Adverum Biotechnologies and Aviceda Therapeutics, will share data at the 2023 meeting in San Francisco, California

AffaMed Technologies is the joint venture between AffaMed Therapeutics and SIFI

Mutations in the EMC1 gene appear to be associated with familial exudative vitreoretinopathy (FEVR), a severe ocular condition.

The price tag of publishing presents a tricky research barrier

Data indicated switching to SB15 from AFL maintained comparable clinical efficacy and safety, confirming biosimilarity between these agents

Academy’s program will take place in San Francisco, California, 3-6 November 2023, before returning to Chicago, Illinois in 2024

With investigations into CVI in the early phases, collaboration across the Atlantic is crucial

An inflammation-based view of both ophthalmic and neurologic health

Every October, World Sight Day brings awareness to the global challenges of blindness and vision impairment

Investigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies

Case 1 highlights the potential for this treatment for patients with dry AMD with noted letter gains

The findings showed significant correlations between positive bacterial cultures and severe ROP, which requires diode laser and anti-VEGF treatment

The 23rd annual EURETINA Congress took place in Amsterdam, the Netherlands. We spoke with Arshad M. Khanani, MD, MA, FASRS, who provided an overview of his presentation, "Emerging therapies for exudative AMD"

ARCATUS, also known as XIPERE®, utilises a revolutionary suprachoroidal delivery platform, offering new hope to patients in China suffering from this vision-threatening condition

Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual EURETINA Congress in Amsterdam, the Netherlands

We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"

For retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options

The new range of pure and premixed gases are intended for medium-term use in retinal surgery